Interestingly, human studies suggest an inverse relationship between the expression of FATP5 and the severity of histologic changes in NAFLD, such as ballooning and fibrosis, suggesting the reduced role of FATP5-mediated TG accumulation as NASH progresses [19,20]. The gene discussed is SLC27A5; the disease is metabolic dysfunction-associated steatotic liver disease.